Insider Financial icon

What Covid? Moderna is Ready to Fight in New Biotech Battleground

Moderna was among the stock darlings that led the meteoric rise of the market, following the ‘Great Pandemic Crash’, as one of the first companies to develop a vaccine to fight Covid19 back in 2021. Since then, Moderna lost some of that ‘star’ status, falling by about 75% from its $497 high, down to as […]

On this website we use first or third-party tools that store small files (cookie) on your device. Cookies are normally used to allow the site to run properly (technical cookies), to generate navigation usage reports (statistics cookies) and to suitable advertise our services/products (profiling cookies). We can directly use technical cookies, but you have the right to choose whether or not to enable statistical and profiling cookies. Enabling these cookies, you help us to offer you a better experience.